Vitamin B12 deficiency

Vitamin B12 deficiency . Vit B12 deficiency in adults is mostly due to a defect in absorption, which is why it is always important to investigate the cause of it.

Summary

[ hide ]

  • 1 Etiology of vitamin B12 deficiency
    • 1 Inadequate(rare) intake
  • 2 Pernicious anemia
    • 1 Pathophysiology
    • 2 Clinical manifestations
    • 3 Gastric complications
    • 4 Clinical associations
  • 3 Diagnosis
  • 4 Source

Etiology of vitamin B12 deficiency

Inadequate (rare) intake

  • Gastric disturbances
    • Pernicious anemia
    • Hereditary absence of normal FI
    • Genetic production of a molecularly altered FI
    • Atrophic gastritis associated with autoimmunity
    • Juvenile pernicious anemia, Hereditary degenerative atrophic gastritis, Acquired gastric atrophy (alcoholism, chronic gastritis), Endocrinopathies (hypo or hyperthyroidism)
  • Gastrectomy
    • Lesions that destroy the gastric mucosa
    • Caustics, Plastic Linitis
  • Alterations in the vit B12-FI complex
    • Antibodies: Blockers, Fixatives
    • Small intestine diseases
      • Gluten-induced enteropathy, Tropical sprue
      • Regional enteritis (Crohn’s), Lymphoma of the small intestine
      • Intestinal tuberculosis, scleroderma, ileal resection
    • Drugs that alter absorption of vit B12
      • PAS, Colchicine, Ethanol, Cimetidine, Ranitidine, Neomycin, Biguanides
    • Vit B12 specific malabsorption
      • Intake of calcium chelators for long periods
      • Inadequate obtaining of alkaline pH in ileum
      • Zollinger-Ellison, Pancreatic disease
    • Alteration of receptors in ileum
      • Congenital: Sme Immerslund Gräsbeck
      • Acquired
    • Competition with vit B12
      • Parasites: Diphylobotrium latum
      • Bacteria: “blind loop syndrome”
      • Pancreatic insufficiency
    • Improper use
      • Congenital or acquired enzymopathies
      • Methylmalonyl CoA mutase, Methylenetetrahydrofolate reductase, Deoxyadenosyl transferase
      • Abnormalities in protein binding to vit B12, causing tissue inaccessibility
      • Increased TC I and III: chronic myeloproliferative syndromes
      • Increased TC II
      • Congenital or acquired transport protein deficiency: Decreased TC II
    • Increased requirements
      • Childhood (growth stage), Pregnancy, Hyperthyroidism
    • Increased excretion
      • Labile junction vit B12 – TC II, Liver disease (inadequate deposition capacity)

We will comment on some particular aspects of specific situations. In chronic pancreatic pathology, the malabsorption of Cb is due to the impossibility of degrading the R proteins of saliva, pancreatic juice and bile, as a consequence of the lack of proteases released by this organ. In Zollinger Ellison syndrome , the pH reaching the ileum is usually acidic, preventing the absorption of the vitamin.

The syndrome Imerslund is hereditary recessive, with emergence of megaloblastic anemia before 2 years of life, associated with persistent proteinuria, the latter does not usually respond to treatment with vit B12, presuming renal tubular defect His resides pathogenesis in a mutation of the ileal receptor (cubilin) ​​of the FI-Cb complex, which prevents its binding to the receptor and, as a consequence, there is a poor absorption of vit B12.

Transport protein abnormalities (TC II deficiency) are expressed as megaloblastic anemia, which usually manifests itself early in life.

Pernicious anemia

Pathophysiology

Pernicious anemia (PA) was described by Thomas Addison in 1849, being Austin Flint, who in 1860, associated it with gastric pathology. It was George Minot in 1926 who reported that ingesting large amounts of raw liver could cure pernicious anemia, a disease of high mortality until then.

This entity includes the association of vit B12 deficiency anemia and chronic atrophic gastritis (Table 7-4). There are two pathophysiological mechanisms to explain it:

  • The destruction and / or progressive loss of the mass of parietal cells, located mainly in the fundus and body

gastric, with the consequent deficit in the production of FI.

  • The presence of “blocking” autoantibodies in gastric juice, which bind to the site of interaction of vit B12, thus preventing the formation of the vit B12-FI complex.

Chronic atrophic gastritis is macroscopically recognized by the loss of gastric folds and thinning of the mucosa. Chronic gastritis can be of two types: type A (autoimmune) and type B (non-autoimmune). From an anatomopathological point of view, gastric biopsy reveals a mononuclear infiltrate (plasma cells, T cells and probably B) in the submucosa extended to the lamina propria, of interglandular distribution. In its evolution, the reduction of the gastric glands, with the loss of the parietal cells, causes them to be replaced by cells with mucous contents, leading to intestinal metaplasia. The progression from chronic type A gastritis to gastric atrophy, and the appearance of the clinical manifestations of anemia, is likely to take between 20 – 30 years, until its expression.

Plasma cells contain autoantibodies against parietal cell and IF antigens. The only proven molecular target of anti-parietal cell antibodies (AACP) is ATPase H + / K + in gastric parietal cells. This is responsible for the secretion of H + ion by these cells, and its replacement by K +. These autoantibodies are unlikely to be pathogenic in vivo, because such ATPase is not accessible to circulating antibodies. The presence of AACP in the serum is a predictor of autoimmune gastritis. The pathogenesis of atrophic gastritis is mediated by CD4 T lymphocytes. The activation of LTh1 results from their interaction with its T cell antigen receptor (TCR), and the ATAase H + / K + β subunit complex with class II molecules of the Main Histocompatibility Complex, on the antigen presenting cell. The intimate mechanism through which activation of the antigen presenting cell occurs, as well as the pathogenic pathway by which the T cell produces gastritis, is unknown.

Clinical manifestations

Known as the “great simulator”, it can manifest itself in multiple ways, with variable sign-symptomatology. A disease with a slow and insidious onset, at the average age of 60 years, with a slight predilection for the female sex. Being more common in people with blue eyes, early gray hair, and blood group A. There is also a genetic predisposition, and around 20% of patients with pernicious anemia can experience this disease in their relatives.

The most frequent form of presentation is due to clinical manifestations of anemia, which may also be a finding in routine laboratory screening. It is common to observe paleness and jaundice, with a straw-colored skin, similar to that observed in hypothyroidism and chronic kidney failure.

The presence of Hunter’s atrophic glossitis (smooth, painful and shiny tongue) is usually a characteristic, although not specific, sign of this deficiency disorder. Occasionally, there may be a diarrheal syndrome and malabsorption. Splenomegaly can be seen in 10-15%.

Vit B12 deficiency can cause peripheral neuropathy and injury to the posterior and lateral cords of the spinal cord (subacute combined degeneration), as well as brain involvement.

The injury progresses from demyelination to axonal degeneration and even neuronal death, which may be irreversible despite the contribution of vit B12.

Such peripheral neuropathy can present in the absence of overt megaloblastic anemia. Distal and symmetrical paresthesias in the hands and feet, as well as hypoesthesia, are an expression of it.

Hypo or apalestesia (deep vibratory sensitivity) and loss of proprioceptive sensitivity (sensation of posture and position), reflect the damage of the posterior medullary cord, as well as sensory ataxia with the presence of the Romberg sign. Limb paresis, spasticity, and Babinsky’s sign express lateral cord damage.

Among the cerebral manifestations can be mentioned the change of character, memory loss, confusion and even a frank psychosis, known as “megaloblastic madness”. Keep in mind that cognitive deficits, fatigue, depression, which are misinterpreted as related to age, may be an expression of vit B12 deficiency, even without anemia.

Cardiovascular manifestations: despite presenting with extremely low hemoglobin, it may show a good tolerance to it, however, fever, expression of intramedullary hemolysis or of an infectious process or associated thyroid disease, can trigger a picture of heart failure. On the other hand, arterial and even venous thrombotic events have been attributed to increased homocysteine ​​levels, a consequence of the deficiency of folic and / or vit B12.

Gastric complications

Achlorhydria, bacterial overgrowth and the development of intestinal metaplasia are all risk factors for the appearance of an adenocarcinoma (AC). PA patients have three times the risk of AC, as well as thirteen times more of carcinoid tumor.

The prevalence of AC in this pathology is 1-3%, while 2% of patients with AC have a PA. Periodic follow-up with fecal occult blood and / or gastric videoendoscopy is recommended in these patients.

Clinical associations

The association of AP with immune endocrinopathies and autoimmune antireceptor diseases is known. Thus it has been found related to: Hashimoto’s thyroiditis , Graves’ disease , vitiligo , hypoparathyroidism , Addison’s disease , primary ovarian failure , insulin-dependent diabetes , primary biliary cirrhosis , ulcerative colitis , myasthenia gravis , [[Eaton Lambert syndrome]], systemic lupus erythematosus , among others.

An association to variable common immunodeficiency, with decreased immunoglobulins or selective Ig A deficiency, has been reported in young patients with type B gastritis .

Diagnosis

  • Blood count. Reveals macrocytic anemia, generally with a MCV greater than 110 fl, and often greater than 120, with reticulocytes

normal or decreased. The presence of leukopenia and / or thrombocytopenia, or a peripheral pancytopenia can be observed. Neutrophil hypersegmentation is characteristic. Elevated LDH and indirect hyperbilirubinemia are expressions of intramedullary hemolysis.

  • Serum dosages: in practice, serum vit B12 dosages are performed, which is usually decreased, as is folate.

intraerythrocyte, the serum concentration of this being normal. Certain considerations should be kept in mind, namely: (i) the serum vit B12 values ​​reflect, the levels of it, linked to its two transporter proteins: haptocorrin and transcobalamin. The latter (TC) represents a fraction close to 30% of the circulating vit B12, being at the same time the only one that releases said vitamin to the cell; (ii) changes in the status of B12 reveal a greater sensitivity for holotranscobalamin (hTC) compared to holohaptocorrin (hHC); (iii) Approximately 15% decrease in serum B12 levels is due to a decrease in hHC, without reflecting a state of B12 deficiency; (iv) These differences in sensitivity and specificity must be taken into account in interpreting the results.

  • Methylmalonic acid (AMM) levels in urine. Methylmalonic aciduria is an expression of serum acid increase

methylmalonic that is observed in patients with vitamin B12 deficiency. It allows a differential diagnosis to be made with folate deficiency, since in the latter the levels of methylmalonic acid are normal.

  • Deoxyuridine (dU) suppression test. It consists of the in vitro incorporation of tritiated deoxythymidine into the marrow cells.

bone and lymphocytes, which is usually abnormal, correcting with the addition of vit B12 and / or AF to the culture medium. It is a very sensitive test, detecting deficiency even in the absence of anemia. Not being of routine use because it requires specialized equipment and material, which is why it has been relegated to research.

  • Schilling test. Test used to assess the absorption of vit B12. It also makes it possible to differentiate a megaloblastic anemia of “gastrogenic” origin from “enterogenic”. It consists of quantifying the urinary excretion of Co58-labeled Cb, delivered orally, having previously fully saturated CT II, ​​by intramuscular administration of 1000 mg of unlabeled Cb. The urine

collected over 24 hours, eliminates between 0 – 2% of the administered dose (normal value:> 5%). The next step is to administer Co58 + FI. If correction is obtained, greater elimination of Co in urine, is due to the fact that there is a deficit of FI, therefore it assumes a gastric (gastrogenic) etiology. In the opposite case, that is, when it does not correct, the problem would reside at the intestinal level (enterogen).

  • Measurement of gastric acidity (pH). Carried out on an empty stomach, it reveals an alkaline pH due to achlorhydria, which is resistant to

histamine or pentagastrin. 25% of patients with sprue or gluten intolerance may also have it.

  • Anti parietal cell autoantibodies. They are detected in almost 90% of patients with AP, and in up to 30% of first-degree relatives without anemia, as well as in those with autoimmune endocrinopathies. In normal subjects, an increase in relation to age is observed (2.5 – 9.6%). The indirect immunofluorescence technique, using mouse stomachs, is used to avoid false positives.
  • Anti-FI autoantibodies (cobalamin-FI complex). Its presence is almost diagnostic of AP and type A gastritis. They can be of two types:

type I or “blockers”: prevent vit B12 from binding to the FI. They are present in 70% of the sera of patients with AP. Type II or “fixatives” which interact with the Vit B12-FI complex preventing its absorption. They are found in 30–40% of patients with PA, and are rarely found in the absence of type I antibodies. Both antibodies can be detected more frequently in gastric juice than in serum.

Hypergastrinemia results in the spread of gastritis to the antrum, and by the stimulation, by achlorhydria, of gastrin-producing G cells. The destruction of the main cells is responsible for the decreased levels of pepsinogen I. Gastric biopsy: perform multiple shots, with the characteristic pathological findings.

 

Leave a Comment

Scroll to Top